We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$24.4B
Cap. Flow %
5.19%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Technology 2.31%
2 Consumer Discretionary 1.61%
3 Financials 1.35%
4 Healthcare 1.15%
5 Communication Services 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWEN icon
12551
Broadwind
BWEN
$107M
-24,631
Closed -$105K
BWG
12552
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$129M
-31,596
Closed -$258K
BWMX icon
12553
Betterware México
BWMX
$593M
-32,906
Closed -$304K
BYD icon
12554
Boyd Gaming
BYD
$5.92B
-25,203
Closed -$1.56M
BZ icon
12555
CALL
Kanzhun
BZ
$7.14B
-66,400
Closed -$1.35M
CAF
12556
Morgan Stanley China A Share Fund
CAF
$316M
-10,193
Closed -$145K
CAE icon
12557
CAE Inc
CAE
$8.1B
-16,418
Closed -$359K
CALC icon
12558
CALL
CalciMedica
CALC
$17.1M
-2,579
Closed -$18.1K
CALC icon
12559
CalciMedica
CALC
$17.1M
-3,204
Closed -$22.4K
CANF
12560
Can-Fite BioPharma American Depositary Shares
CANF
$7.2M
-164
Closed -$20.1K
CARM
12561
DELISTED
Carisma Therapeutics
CARM
-21,722
Closed -$207K
CATX icon
12562
Perspective Therapeutics
CATX
$378M
-1,935
Closed -$4.78K
CATY icon
12563
CALL
Cathay General Bancorp
CATY
$4.14B
-7,400
Closed -$302K
CBLS icon
12564
Clough Hedged Equity ETF
CBLS
$56.5M
-11,425
Closed -$242K
CCB icon
12565
CALL
Coastal Financial
CCB
$726M
-13,100
Closed -$623K
CCCC icon
12566
CALL
C4 Therapeutics
CCCC
$512M
-18,900
Closed -$112K
CCO icon
12567
PUT
Clear Channel Outdoor Holdings
CCO
$1.21B
-71,200
Closed -$74.8K
CCRV
12568
DELISTED
iShares Commodity Curve Carry Strategy ETF
CCRV
-18,066
Closed -$362K
CDIO icon
12569
Cardio Diagnostics
CDIO
$5.77M
-788
Closed -$26.2K
CDIOW icon
12570
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$662K
-12,483
Closed -$618
CELU icon
12571
PUT
Celularity
CELU
$23.7M
-1,210
Closed -$15.6K
CENN icon
12572
PUT
Cenntro
CENN
$9.65M
-65
Closed -$17.1K
CFSB
12573
DELISTED
CFSB Bancorp
CFSB
-19,953
Closed -$161K
CGBD icon
12574
Carlyle Secured Lending
CGBD
$782M
-31,800
Closed -$468K
CGMS icon
12575
Capital Group US Multi-Sector Income ETF
CGMS
$5.47B
-7,789
Closed -$200K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $24.4B of net new capital in Q1 2023, opening 2,075 new positions and adding to 5,756 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $1.62B trimmed.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.